Moderna reached a new phase in its COVID-19 vaccine trials on children, the company said in a statement, a significant move to get as many people vaccinated as possible. The company's KidCOVE study will enroll 6,750 children between 6 months and 11 years old in the U.S. and Canada, according to CNN. 'We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the U.S. and Canada,' Moderna CEO Stéphane Bancel said in a press release. 'This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important […]
The post Moderna starts COVID-19 vaccine trials on children appeared first on BNC.
